CONNIE JONES: Open Payments
NPI 1225414238 · CALERA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 59 payments from 18 companies in 2025. Trend: 2023 $1,109 · 2024 $1,752 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $238 |
| ABBVIE INC. | 9 | $153 |
| Novo Nordisk Inc | 6 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $87 |
| Lilly USA, LLC | 4 | $84 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Abbott Laboratories | 3 | $64 |
| Inari Medical, Inc. | 2 | $61 |
| Amgen Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: Ozempic, FLOWTRIEVER CATHETER, S, CAPLYTA, AIRSUPRA, FARXIGA, BREZTRI, Kerendia, FREESTYLE LIBRE 3.
Industry payments across AL — which companies pay providers there.
